Efficacy of medical therapies for fistulizing Crohn's disease: systematic review and meta-analysis
MJ Lee, CE Parker, SR Taylor, L Guizzetti… - Clinical …, 2018 - Elsevier
Background & Aims Fistulas are debilitating complications of Crohn's disease (CD) that
affect up to 50% of patients. We conducted a systematic review and meta-analysis of …
affect up to 50% of patients. We conducted a systematic review and meta-analysis of …
Guidelines for the management of inflammatory bowel disease in adults
MJ Carter, AJ Lobo, SPL Travis - Gut, 2004 - gut.bmj.com
Guidelines for the management of inflammatory bowel disease in adults | Gut Skip to main
content Viewing from: Google Indexer BMJ Journals Subscribe Log In More Log in via …
content Viewing from: Google Indexer BMJ Journals Subscribe Log In More Log in via …
Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care
DS Sanders, MJ Carter, DP Hurlstone, A Pearce… - The Lancet, 2001 - thelancet.com
Background Irritable bowel syndrome has a high prevalence. Consensus diagnostic criteria
(ROME II) based on symptoms have been established to aid diagnosis. Although coeliac …
(ROME II) based on symptoms have been established to aid diagnosis. Although coeliac …
Matrix metalloproteinase levels are elevated in inflammatory bowel disease
MD Baugh, MJ Perry, AP Hollander, DR Davies… - Gastroenterology, 1999 - Elsevier
Background & Aims: The expression of matrix metalloproteinases 1, 2, 3, and 9 was
examined in biopsy specimens removed from adult and pediatric patients with ulcerative …
examined in biopsy specimens removed from adult and pediatric patients with ulcerative …
A primary care cross-sectional study of undiagnosed adult coeliac disease
DS Sanders, D Patel, TJ Stephenson… - European journal of …, 2003 - journals.lww.com
Objectives To establish the prevalence of coeliac disease in the general population and in
specific conditions, such as irritable bowel syndrome, iron deficiency anaemia, fatigue and …
specific conditions, such as irritable bowel syndrome, iron deficiency anaemia, fatigue and …
[HTML][HTML] Prediction of relapse after anti–tumor necrosis factor cessation in Crohn's disease: individual participant data meta-analysis of 1317 patients from 14 studies
RWM Pauwels, CJ van der Woude, D Nieboer… - Clinical …, 2022 - Elsevier
Background & Aims Tools for stratification of relapse risk of Crohn's disease (CD) after anti–
tumor necrosis factor (TNF) therapy cessation are needed. We aimed to validate a …
tumor necrosis factor (TNF) therapy cessation are needed. We aimed to validate a …
Keratins in colorectal epithelial function and disease
D Majumdar, JP Tiernan, AJ Lobo… - International journal …, 2012 - Wiley Online Library
Keratins are the largest subgroup of intermediate filament proteins, which are an important
constituent of the cellular cytoskeleton. The principally expressed keratins (K) of the …
constituent of the cellular cytoskeleton. The principally expressed keratins (K) of the …
Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool
AD Hopper, SS Cross, DP Hurlstone, ME McAlindon… - Bmj, 2007 - bmj.com
Objective To determine an effective diagnostic method of detecting all cases of coeliac
disease in patients referred for gastroscopy without performing routine duodenal biopsy …
disease in patients referred for gastroscopy without performing routine duodenal biopsy …
What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis
AD Hopper, M Hadjivassiliou, DP Hurlstone… - Clinical …, 2008 - Elsevier
Background & Aims: The optimal serologic tests for the detection of celiac disease and
follow-up assessment remains controversial. Our aim was to evaluate all current …
follow-up assessment remains controversial. Our aim was to evaluate all current …
Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis
JRB Green, AJ Lobo, CD Holdsworth, RJ Leicester… - Gastroenterology, 1998 - Elsevier
Background & Aims: Aminosalicylates are widely used in the treatment of ulcerative colitis
(UC). Balsalazide is a novel mesalamine prodrug, activated by colonic bacteria. The aim of …
(UC). Balsalazide is a novel mesalamine prodrug, activated by colonic bacteria. The aim of …